|
|
|
| Key Considerations When Choosing A Device For Dry Powder Nasal Delivery | Dry powder nasal delivery is attracting growing interest as developers seek alternatives to traditional liquid nasal sprays. From improved stability and higher drug loading to enhanced bioavailability, the approach offers several compelling advantages. However, selecting the right device is critical to achieving successful drug delivery and clinical outcomes. This article explores the key factors that influence device selection, highlighting why early alignment between formulation and device development can help accelerate programmes and maximise product performance. Read more. |
|
|
|
|
|
| Considerations When Outsourcing Your Packaging Operations | Q&A | By Yves Massicotte, Ropack Pharma Solutions | View the key to maintaining and enhancing existing and new partnerships as well as how outsourcing one crucial aspect of bringing products to market can benefit overall supply chain optimization. |
|
|
|
|
By Jeffrey S. Buguliskis, Ph.D., Deputy Chief Editor, Outsourced Pharma | A green CDMO quality dashboard can mask repeated deadline extensions, shallow “human error” investigations, and facility-wide excursions unless sponsors look past headline percentages to examine how the underlying metrics are built. | |
|
|
Is It Time To Leave Your CDMO? | By Outsourced Pharma Live | This segment of the Outsourced Pharma Live event, “Your CDMO Quality Oversight Is Not Working,” examines how sponsors can determine whether a troubled CDMO relationship can be repaired. |
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
|
|
| Accelerated Development Of OSD Formulation For IND Submission | White Paper | By Saujanya Gosangari, Alcami | This paper highlights how the roller compaction process not only enhances efficiency but also improves the scalability of solid oral dosage production, supporting rapid development for regulatory approval. |
|
|
| Navigating The Development Of Dry Powder For Inhalation | White Paper | By Beatriz Noriega-Fernandes, Mariam Ibrahim, Rui Cruz, et al., Lonza | Navigate Dry Powder Inhaler Development With Confidence. Explore key considerations for TPP definition, API characterization, particle engineering, technology selection, and encapsulation. |
|
|
|
|
|
|
|
|
|
|
|
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|